课题基金 / 基金详情

项目摘要

项目成果

JAMES Culvin MORRIS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary The goal of this proposal is to develop molecular tools and approaches for the study of the pathogenic free-living amoeba Naegleria fowleri. These currently do not exist. This amoeba is the causative agent of primary amebic meningoencephalitis (PAM), an almost invariable lethal brain infection. The lack of useful drugs for the treatment of this infection emphasizes the need to develop better therapeutic agents for amoebae infections. The lack of understanding of gene function in the parasite remains a major hurdle in target-based drug development campaigns. Here, we propose to address this problem by developing approaches for gene silencing and ablation by RNAi and CRISP/Cas9-mediate gene editing and transgene expression. These approaches will serve as an important first step in understanding both gene function and essentiality, key to early-stage drug discovery efforts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enolase inhibitors as therapeutic leads for Naegleria fowleri infections
  • 批准号:
    10739388
  • 项目类别:
  • 资助金额:
    $20.54万
  • 财政年份:
    2023
  • 负责人:
    JAMES Culvin MORRIS
  • 依托单位:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
  • 批准号:
    10494462
  • 项目类别:
  • 资助金额:
    $220.95万
  • 财政年份:
    2022
  • 负责人:
    JAMES Culvin MORRIS
  • 依托单位:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
  • 批准号:
    10666653
  • 项目类别:
  • 资助金额:
    $221.43万
  • 财政年份:
    2022
  • 负责人:
    JAMES Culvin MORRIS
  • 依托单位:
Acquisition of the Agilent Cytation C10 confocal imaging reader for enhancing biomedical research excellence at Clemson University
  • 批准号:
    10798537
  • 项目类别:
  • 资助金额:
    $29.61万
  • 财政年份:
    2022
  • 负责人:
    JAMES Culvin MORRIS
  • 依托单位:
海外基金